Salus University, STAAR Surgical Launch Project MyVision

The Pennsylvania College of Optometry (PCO) at Salus University and its clinical facility, The Eye Institute (TEI), recently partnered with STAAR Surgical, a leading developer and manufacturer of implantable lenses and companion delivery systems for the eye, to launch Project MyVision, a charitable lens-based refractive surgery program.  

Under the new partnership, STAAR will donate Implantable Collamer® Lenses (ICLs) to underserved, low-income patients diagnosed with myopia (nearsightedness) which is the need for distance vision correction. Myopia is the most common vision disorder globally and its prevalence is rapidly growing.

David Friess, OD ‘02, Resident ’03, FAAO and former president of the University’s Alumni Association was instrumental in developing the partnership between STAAR and Salus University. “The ICL is an elective surgical procedure designed to provide individuals visual freedom from contact lenses and glasses and this new partnership between Salus University and STAAR Surgical will expand access to individuals who may not have the economic resources to consider refractive surgery,” said Dr. Friess who is currently vice president, global medical affairs at STAAR Surgical. “We believe Project MyVision can also benefit PCO/Salus students during their clinical training by exposing them to the benefits of vision correction with lens-based refractive surgery and potentially opening new career paths for work in collaboration with surgeons and surgical practices. We are honored to partner with Salus University.”

James Lewis, MD, a Salus University consulting ophthalmologist specializing in cornea, cataract and refractive surgery based in Elkins Park, Pennsylvania, will perform the ICL procedures for Project MyVision. Use of facilities, equipment and personnel support are being provided by the Fort Washington Surgery Center in Fort Washington, Pennsylvania.

“This technology offers better vision and safety for many patients with nearsightedness and astigmatism. STAAR Surgical, the manufacturer of the Visian ICL and EVO, selected us to introduce this philanthropic program to the country,” Dr. Lewis said. “Project MyVision will enhance the education of Salus University students and benefit many patients in our clinic at The Eye Institute. The nearby Fort Washington Surgery Center has made this possible through its substantial donation of time and resources. We hope to expand the understanding and appreciation of this life-changing implant.”

The goal of Project MyVision is to provide ICL lens implant surgery to patients receiving vision care through The Eye Institute of Salus University with moderate to severe myopia. STAAR’s implantable lenses are designed to correct nearsightedness for people who are often very dependent on their glasses or contact lenses and the procedure is not covered by health insurance providers.

“The approach we're taking with Project MyVision is really about assisting communities with vision needs and expanding our charitable efforts,” said Heather Ready, senior director of global market intelligence at STAAR. “We believe our partnership with PCO/Salus is a great opportunity to serve individuals who have high need and limited access.”

The initial ICL implant surgeries performed by Dr. Lewis were completed last month. Salus and STAAR hope Project MyVision can grow within the community and beyond.